To start page
2012-2-23 +/-% Buy Sell Latest Volume Turnover (SEK)
NVP -7.04% 18.50 18.60 18.50 65 845 1 231 429.10
  • Home
  • About NeuroVive
  • Research & Development
  • Investors
  • Contact
Investors
  • Contacts
  • News releases
  • In the News
  • Stock
  • Shareholder reports
  • Corporate governance
  • Analyst coverage
  • Presentations
  • Ownership
  • Calendar
  • Financial calendar
Start / Investors / Calendar

Calendar

  • 2013
  • 2012
  • 2011

Calendar

Subscribe
2012 Feb 1 - 2012 Feb 2
NeuroVive presents business model for industry partnership in Munich Conference - Clinical...
2012 Feb 21
Year-End report 2011
2012 Mar 6 - 2012 Mar 7
NeuroVive presents at the 2nd Annual Traumatic Brain Injury Conference in Washington, US, 6-7 Mar...
2012 Apr 23 - 2012 Apr 27
Annual report 2011
2012 May 31
Interim report January - March 2012
2012 Jun 8
Annual meeting 2012
2012 Aug 21
Semi-annual report January - June 2012
2012 Nov 20
Interim report January - September 2012
  • About NeuroVive
    • In brief
    • Board of Directors
    • Management Team
    • Advisory Board
    • Corporate Governance
    • Partnerships
    • Career
  • Research & Development
    • Project overview
    • Research overview
    • Our products
    • Relevant publications
  • Investors
    • Contacts
    • News releases
    • In the News
    • Stock
    • Shareholder reports
    • Corporate governance
    • Analyst coverage
    • Presentations
    • Ownership
    • Calendar
    • Financial calendar
  • Contact
    • Investors
    • Business development
    • Research
    • How to find us

NeuroVive Pharmaceutical AB (publ), Biomedical Center, BMC D10, SE-221 84 Lund, Sweden

Tel: +46 (0)46 288 01 10 | Fax: +46 (0)46 888 83 48 | info@neurovive.com | Legal & Privacy